Abstract:Medical progress has historically depended on scientific discoveries. Until recently, science was driven by technological advancements that, once translated to the clinic, fostered new treatments and interventions. More recently, technology-driven medical progress has often outpaced laboratory research. For example, intravascular devices, pacemakers for the heart and brain, spinal cord stimulators, and surgical robots are used routinely to treat a variety of diseases. The rapid expansion of science into ever more advanced molecular and genetic mechanisms of disease has often distanced laboratory-based research from day-to-day clinical realities that remain based on evidence and outcomes. A recognized reason for this hiatus is the lack of laboratory tools that recapitulate the clinical reality faced by physicians and surgeons. To overcome this, the NIH and FDA have in the recent past joined forces to support the development of a "human-on-a-chip" that will allow research scientists to perform experiments on a realistic replica when testing the effectiveness of novel experimental therapies. The development of a "human-on-a-chip" rests on the capacity to grow in vitro various organs-on-a-chip, connected with appropriate vascular supplies and nerves, and our ability to measure and perform experiments on these virtually invisible organs. One of the tissue structures to be scaled down on a chip is the human blood-brain barrier. This review gives a historical perspective on in vitro models of the BBB and summarizes the most recent 3D models that attempt to fill the gap between research modeling and patient care. We also present a summary of how these in vitro models of the BBB can be applied to study human brain diseases and their treatments. We have chosen NeuroAIDS, COVID-19, multiple sclerosis, and Alzheimer's disease as examples of in vitro model application to neurological disorders. Major insight pertaining to these illnesses as a consequence of more profound understanding of the BBB can reveal new avenues for the development of diagnostics, more efficient therapies, and definitive clarity of disease etiology and pathological progression.

Paving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells

Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier

Recent advances in human iPSC-derived models of the blood–brain barrier

Vascularizing the brain <i>in vitro</i>

Tissue-engineered blood-brain barrier models via directed differentiation of human induced pluripotent stem cells

Extracellular matrix proteins in construction and function of in vitro blood-brain barrier models

In vitro Models of the Blood-Brain Barrier: Tools in Translational Medicine

Electrospun Scaffolds as Cell Culture Substrates for the Cultivation of an In Vitro Blood–Brain Barrier Model Using Human Induced Pluripotent Stem Cells

Modeling blood-brain barrier formation and cerebral cavernous malformations in human PSC-derived organoids

Functional Blood-Brain Barrier Model with Tight Connected Minitissue by Liquid Substrates Culture.

Human mini-blood–brain barrier models for biomedical neuroscience research: a review

Microphysiological Blood‐Brain Barrier Systems for Disease Modeling and Drug Development

An In Vitro Model of the Blood-Brain Barrier for the Investigation and Isolation of the Key Drivers of Barriergenesis

Experimental Models to Study the Functions of the Blood–Brain Barrier

A Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells

3D hydrogel models of the neurovascular unit to investigate blood-brain barrier dysfunction

3D brain angiogenesis model to reconstitute maturation of functional human blood-brain barrier in vitro

TGF-β and SHH Regulate Pluripotent Stem Cell Differentiation into Brain Microvascular Endothelial Cells in Generating an In Vitro Blood–Brain Barrier Model

Progresses in the establishment, evaluation, and application of in vitro blood–brain barrier models

Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: from 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases